Davis Todd C - Insider Non-Derivative Transactions at Chromocell Therapeutics Corp (CHRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 21, 2024, Davis Todd C's relationship to Chromocell Therapeutics Corp (CHRO) is Director, and currently has 29,167 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CHRO insiders.
Data Source: SEC.
Davis Todd C - Insider Non-Derivative Transactions at CHRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 22, 2024 | M -- (Common Stock) | 29167 | 4.8 | 29167 |